Amy Banse
Amy Banse's purchase track record
How the stock did after each of Amy Banse's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/10/2024 | LEN | $247K | -6.2% | +16.5% | +12.2% |
| 1/5/2024 | ADBE | $9K | -14.1% | +2.4% | +18.5% |
| 10/13/2023 | LEN | $100K | +38.8% | +46.8% | +18.4% |
| 8/15/2023 | LEN | $202K | +2.1% | +21.1% | +11.6% |
| 7/21/2023 | LEN | $100K | -17.8% | +20.3% | +6.7% |
| 6/22/2023 | LEN | $20K | -6.5% | +22.7% | +8.3% |
| 6/21/2023 | ADBE | $20K | +12.2% | +24.8% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
On Holding faces scrutiny over premium pricing and sales targets. Recent reports question whether On Holding can sustain its growth trajectory while maintaining a premium pricing strategy. The company is targeting nearly $7 billion in sales, a goal that raises questions about market saturation and consumer demand. These headlines come as the stock has recently declined more sharply than the broader market, highlighting potential risks in the consumer sector.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ADBE Shares Fall as AI Software Competition Heats Up. Adobe shares have fallen more than the broader market recently, with analysts questioning whether it can keep pace with AI-driven rivals like Salesforce. News coverage has focused on how Adobe stacks up against competitors in the software industry and whether its cash position justifies its valuation. The stock is trading well below its 52-week high of $363.70, and technical signals show it is testing key support near $237.67.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Clorox Launches Purell ProCare Amidst Broader Consumer Stock Weakness. Clorox introduced its new Purell ProCare product line, adding to recent discussions about its digital expansion and innovation efforts. The stock is currently trading near its 52-week low, with an RSI of 31.1 indicating oversold conditions. Analysts maintain an average price target of $100.47, while the company offers a 3.40% dividend yield.
Transaction History
| LEN | ▲ Buy | Grant | 15 | $1K | 10/7/2026 | View on chart |
| ONON | ▲ Buy | Grant | 2,433 | — | 9/21/2026 | View on chart |
| LEN | ▲ Buy | Grant | 14 | $1K | 7/10/2026 | View on chart |
| ONON | ▲ Buy | Grant | 1,736 | — | 6/22/2026 | View on chart |
| LEN | ▲ Buy | Grant | 12 | $1K | 4/22/2026 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 900 | $0 | 4/15/2026 | View on chart |
| LEN | ▲ Buy | Grant | 2,313 | $0 | 4/8/2026 | View on chart |
| ONON | ▲ Buy | Grant | 1,689 | — | 3/24/2026 | View on chart |
| LEN | ▲ Buy | Grant | 133 | $0 | 11/28/2025 | View on chart |
| LEN | ▼ Sell | Other | 220 | — | 11/26/2025 | View on chart |
| LEN | ▲ Buy | Grant | 131 | $0 | 8/29/2025 | View on chart |
| LEN | ▲ Buy | Grant | 164 | $0 | 5/30/2025 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 633 | $0 | 4/22/2025 | View on chart |
| LEN | ▲ Buy | Grant | 1,242 | $0 | 4/9/2025 | View on chart |
| LEN | ▲ Buy | Grant | 146 | $0 | 2/28/2025 | View on chart |
| ADBE | ▼ Sell | Open Market | 606 | $333K | 12/6/2024 | View on chart |
| LEN | ▲ Buy | Grant | 100 | $0 | 11/29/2024 | View on chart |
| CLX | ▲ Buy | Grant | 161 | $26K | 9/30/2024 | View on chart |
| LEN | ▲ Buy | Grant | 96 | $0 | 8/30/2024 | View on chart |
| CLX | ▲ Buy | Grant | 192 | $26K | 6/28/2024 | View on chart |
| LEN | ▲ Buy | Grant | 109 | $0 | 5/31/2024 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 836 | $0 | 4/17/2024 | View on chart |
| LEN | ▲ Buy | Open Market | 1,575 | $247K | 4/10/2024 | View on chart |
| LEN | ▲ Buy | Grant | 863 | $0 | 4/10/2024 | View on chart |
| CLX | ▲ Buy | Grant | 171 | $26K | 3/28/2024 | View on chart |
| LEN | ▲ Buy | Grant | 110 | $0 | 2/29/2024 | View on chart |
| ADBE | ▲ Buy | Open Market | 15 | $9K | 1/5/2024 | View on chart |
| LEN | ▲ Buy | Grant | 136 | $0 | 11/30/2023 | View on chart |
| LEN | ▲ Buy | Open Market | 920 | $100K | 10/13/2023 | View on chart |
| LEN | ▲ Buy | Grant | 146 | $0 | 8/31/2023 | View on chart |
| LEN | ▲ Buy | Open Market | 859 | $101K | 8/17/2023 | View on chart |
| LEN | ▲ Buy | Open Market | 820 | $101K | 8/15/2023 | View on chart |
| LEN | ▲ Buy | Open Market | 790 | $100K | 7/21/2023 | View on chart |
| LEN | ▲ Buy | Open Market | 165 | $20K | 6/22/2023 | View on chart |
| ADBE | ▲ Buy | Open Market | 40 | $20K | 6/21/2023 | View on chart |
| LEN | ▲ Buy | Grant | 163 | $0 | 5/31/2023 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 672 | $0 | 4/20/2023 | View on chart |
| LEN | ▲ Buy | Grant | 1,280 | $0 | 4/12/2023 | View on chart |
| LEN | ▲ Buy | Grant | 180 | $0 | 2/28/2023 | View on chart |
| LEN | ▲ Buy | Grant | 199 | $0 | 11/30/2022 | View on chart |
| LEN | ▲ Buy | Grant | 225 | $0 | 8/31/2022 | View on chart |
| LEN | ▲ Buy | Grant | 218 | $0 | 5/31/2022 | View on chart |
| ADBE | ▲ Buy | Option Exercise | 615 | $0 | 4/14/2022 | View on chart |
| LEN | ▲ Buy | Grant | 1,764 | $0 | 4/12/2022 | View on chart |
| LEN | ▲ Buy | Grant | 194 | $0 | 2/28/2022 | View on chart |
| LEN | ▲ Buy | Grant | 166 | $0 | 11/30/2021 | View on chart |
| LEN | ▲ Buy | Grant | 163 | $0 | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Lennar faces short interest scrutiny and Las Vegas expansion
Lennar is drawing attention after a short-seller report flagged the company alongside peers, adding to recent stock weakness. The homebuilder also announced a new development in downtown Las Vegas to expand affordable housing options. These events occur while the stock trades near its support level, reflecting mixed sentiment on the company's outlook.
Lennar faces short interest scrutiny and Las Vegas expansion. Lennar is drawing attention after a short-seller report flagged the company alongside peers, adding to recent stock weakness. The homebuilder also announced a new development in downtown Las Vegas to expand affordable housing options. These events occur while the stock trades near its support level, reflecting mixed sentiment on the company's outlook.